Over the last decade, observers of the US pharmaceutical market witnessed something remarkable.
April 18, 2018US demand for analytical instruments is forecast to total $50.2 billion in 2021. Much of this increased demand stems from the need for pharmaceutical companies to produce novel drugs in the face of a laundry list of expiring patents in the coming months and years. Without new pharmaceutical developments, companies’ profits will plummet as their blockbuster medications are exposed to competition from third parties producing generic formulations.
December 12, 2017